Oncimmune raises €11.1M Post IPO round
31 March 2021· Leeds, United Kingdom· health, biotechnology, diagnostics, ai, b2b, software_hardware
to invest in capacity and capability out of its Dortmund facility in Germany and to build a business development team in the US
About Oncimmune
Stage
Post IPO
Headquarters
Leeds, United Kingdom
Founded
2002
Team Size
21–50
Sectors
healthbiotechnologydiagnosticsaib2bsoftware_hardware